NovoCure Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.43 | -$0.41 | -$0.42 |
| Q2 2024 | 3 | -$0.41 | -$0.39 | -$0.40 |
| Q3 2024 | 2 | -$0.34 | -$0.32 | -$0.33 |
| Q4 2024 | 6 | -$0.42 | -$0.27 | -$0.35 |
| Q1 2025 | 3 | -$0.44 | -$0.32 | -$0.38 |
| Q2 2025 | 2 | -$0.39 | -$0.37 | -$0.38 |
| Q3 2025 | 2 | -$0.39 | -$0.36 | -$0.38 |
| Q4 2025 | 2 | -$0.42 | -$0.40 | -$0.41 |
NovoCure Limited Earnings Date And Information
NovoCure Limited last posted its earnings results on Wednesday, October 30th, 2024. The company reported $-0.28 earnings per share for the quarter, topping analysts' consensus estimates of $-0.34 by $0.06. The company had revenue of 155.10 M for the quarter and had revenue of 509.34 M for the year. NovoCure Limited has generated $-2 earnings per share over the last year ($-1.95 diluted earnings per share) and currently has a price-to-earnings ratio of -12.76. NovoCure Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
NovoCure Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/30/2024 | Q3 2024 | -$0.34 | -$0.28 | 0.06 | $143.95 M | $155.10 M |
| 07/25/2024 | Q2 2024 | -$0.40 | -$0.31 | 0.09 | $135.83 M | $150.36 M |
| 05/02/2024 | Q1 2024 | -$0.43 | -$0.36 | 0.07 | $138.50 M | |
| 02/22/2024 | Q4 2023 | -$0.53 | -$0.44 | 0.09 | $133.78 M | |
| 10/26/2023 | Q3 2023 | -$0.52 | -$0.46 | 0.06 | $128.75 M | $127.32 M |
| 07/27/2023 | Q2 2023 | -$0.50 | -$0.54 | -0.04 | $124.25 M | $126.05 M |
| 05/04/2023 | Q1 2023 | -$0.36 | -$0.50 | -0.14 | $122.18 M | |
| 02/23/2023 | Q4 2022 | -$0.32 | -$0.36 | -0.04 | $128.43 M | |
| 10/27/2022 | Q3 2022 | -$0.30 | -$0.25 | 0.05 | $130.61 M | $131.00 M |
| 07/28/2022 | Q2 2022 | -$0.14 | -$0.23 | -0.09 | $134.97 M | $140.87 M |
| 04/28/2022 | Q1 2022 | -$0.17 | -$0.04 | 0.13 | $137.55 M | |
| 02/24/2022 | Q4 2021 | -$0.10 | -$0.25 | -0.15 | $133.21 M | |
| 10/28/2021 | Q3 2021 | -$0.06 | -$0.13 | -0.07 | $141.27 M | $133.61 M |
| 07/29/2021 | Q2 2021 | -$0.01 | -$0.14 | -0.13 | $141.50 M | $133.52 M |
| 04/29/2021 | Q1 2021 | -$0.01 | -$0.04 | -0.03 | $134.70 M | |
| 02/25/2021 | Q4 2020 | $0.12 | $0.05 | -0.07 | $143.95 M | |
| 10/29/2020 | Q3 2020 | $0.03 | $0.09 | 0.06 | $119.51 M | $132.66 M |
| 07/30/2020 | Q2 2020 | $0.00 | $0.02 | 0.02 | $105.70 M | $115.93 M |
| 04/30/2020 | Q1 2020 | $0.02 | $0.04 | 0.02 | $101.83 M | |
| 02/27/2020 | Q4 2019 | $0.02 | $0.04 | 0.02 | $99.23 M |
NovoCure Limited Earnings: Frequently Asked Questions
-
When is NovoCure Limited's earnings date?
NovoCure Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
Did NovoCure Limited beat their earnings estimates last quarter?
In the previous quarter, NovoCure Limited (:NVCR) reported $-0.28 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.34 by $0.06.
-
How can I listen to NovoCure Limited's earnings conference call?
The conference call for NovoCure Limited's latest earnings report can be listened to online.
-
How can I read NovoCure Limited's conference call transcript?
The conference call transcript for NovoCure Limited's latest earnings report can be read online.
-
How much revenue does NovoCure Limited generate each year?
NovoCure Limited (:NVCR) has a recorded annual revenue of $509.34 M.
-
How much profit does NovoCure Limited generate each year?
NovoCure Limited (:NVCR) has a recorded net income of $509.34 M. NovoCure Limited has generated $-1.95 earnings per share over the last four quarters.
-
What is NovoCure Limited's price-to-earnings ratio?
NovoCure Limited (:NVCR) has a price-to-earnings ratio of -12.76 and price/earnings-to-growth ratio is -1.11.
